<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Aging Neurosci.</journal-id>
<journal-title>Frontiers in Aging Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Aging Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1663-4365</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnagi.2017.00024</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Presynaptic Muscarinic Acetylcholine Receptors and TrkB Receptor Cooperate in the Elimination of Redundant Motor Nerve Terminals during Development</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Nadal</surname> <given-names>Laura</given-names></name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Garcia</surname> <given-names>Neus</given-names></name>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/402731/overview"/>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Hurtado</surname> <given-names>Erica</given-names></name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sim&#x000F3;</surname> <given-names>Anna</given-names></name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Tom&#x000E0;s</surname> <given-names>Marta</given-names></name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Lanuza</surname> <given-names>Maria A.</given-names></name>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Cilleros</surname> <given-names>Victor</given-names></name>
<xref ref-type="aff" rid="aff1"/>
</contrib> 
<contrib contrib-type="author" corresp="yes">
<name><surname>Tom&#x000E0;s</surname> <given-names>Josep</given-names></name>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<xref ref-type="aff" rid="aff1"/>
</contrib>
</contrib-group>
<aff id="aff1"><institution>Unitat d&#x02019;Histologia i Neurobiologia (UHN), Facultat de Medicina i Ci&#x000E8;ncies de la Salut, Universitat Rovira i Virgili</institution> <country>Reus, Spain</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Antonio Camins, University of Barcelona, Spain</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Daniel Ortu&#x000F1;o-Sahag&#x000FA;n, Centro Universitario de Ciencias de la Salud, Mexico; Jordi Olloquequi, Universidad Aut&#x000F3;noma de Chile, Chile</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Neus Garcia <email>mariadelesneus.garcia&#x00040;urv.cat</email> Josep Tom&#x000E0;s <email>josepmaria.tomas&#x00040;urv.cat</email></p></fn>
<fn fn-type="other" id="fn002"><p><sup>&#x02020;</sup> These authors have contributed equally to this work.</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>02</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>9</volume>
<elocation-id>24</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>01</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Nadal, Garcia, Hurtado, Sim&#x000F3;, Tom&#x000E0;s, Lanuza, Cilleros and Tom&#x000E0;s.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Nadal, Garcia, Hurtado, Sim&#x000F3;, Tom&#x000E0;s, Lanuza, Cilleros and Tom&#x000E0;s</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract><p>The development of the nervous system involves the overproduction of synapses but connectivity is refined by Hebbian activity-dependent axonal competition. The newborn skeletal muscle fibers are polyinnervated but, at the end of the competition process, some days later, become innervated by a single axon. We used quantitative confocal imaging of the autofluorescent axons from transgenic B6.Cg-Tg (Thy1-YFP)16 Jrs/J mice to investigate the possible cooperation of the muscarinic autoreceptors (mAChR, M<sub>1</sub>-, M<sub>2</sub>- and M<sub>4</sub>-subtypes) and the tyrosine kinase B (TrkB) receptor in the control of axonal elimination after the mice <italic>Levator auris longus (LAL)</italic> muscle had been exposed to several selective antagonist of the corresponding receptor pathways <italic>in vivo</italic>. Our previous results show that M<sub>1</sub>, M<sub>2</sub> and TrkB signaling individually increase axonal loss rate around P9. Here we show that although the M<sub>1</sub> and TrkB receptors cooperate and add their respective individual effects to increase axonal elimination rate even more, the effect of the M<sub>2</sub> receptor is largely independent of both M<sub>1</sub> and TrkB receptors. Thus both, cooperative and non-cooperative signaling mechanisms contribute to developmental synapse elimination.</p></abstract>
<kwd-group>
<kwd>motor nerve terminal</kwd>
<kwd>cholinergic synapses</kwd>
<kwd>neuromuscular junction</kwd>
<kwd>presynaptic muscarinic acetylcholine receptors</kwd>
<kwd>TrkB receptor</kwd>
<kwd>synapse elimination</kwd>
</kwd-group>
<contract-num rid="cn001">SAF2015-67143-P</contract-num>
<contract-num rid="cn002">2014SGR344</contract-num>
<contract-sponsor id="cn001">Ministerio de Econom&#x000ED;a y Competitividad<named-content content-type="fundref-id">10.13039/501100003329</named-content></contract-sponsor>
<contract-sponsor id="cn002">Generalitat de Catalunya<named-content content-type="fundref-id">10.13039/501100002809</named-content></contract-sponsor>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="39"/>
<page-count count="7"/>
<word-count count="5351"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="introduction" id="s1">
<title>Introduction</title>
<p>During the development of the nervous system, synapses are eliminated on a broad scale (Thompson, <xref ref-type="bibr" rid="B33">1985</xref>; Bourgeois and Rakic, <xref ref-type="bibr" rid="B3">1993</xref>). This allows connectivity to be refined on the basis of Hebbian activity-dependent axonal competition (Jansen and Fladby, <xref ref-type="bibr" rid="B12">1990</xref>; Sanes and Lichtman, <xref ref-type="bibr" rid="B23">1999</xref>). In newborn animals, the skeletal muscle fibers are polyinnervated in the neuromuscular junction area (NMJ; Redfern, <xref ref-type="bibr" rid="B21">1970</xref>; Brown et al., <xref ref-type="bibr" rid="B4">1976</xref>; Ribchester and Barry, <xref ref-type="bibr" rid="B22">1994</xref>), but at the end of the axonal competition, endplates are innervated by a single axon (Benoit and Changeux, <xref ref-type="bibr" rid="B2">1975</xref>; O&#x02019;Brien et al., <xref ref-type="bibr" rid="B20">1978</xref>; Jansen and Fladby, <xref ref-type="bibr" rid="B12">1990</xref>; Sanes and Lichtman, <xref ref-type="bibr" rid="B23">1999</xref>). This peripheral synapse has been studied extensively as a model for synapse development (Liu et al., <xref ref-type="bibr" rid="B16">1994</xref>; Nguyen and Lichtman, <xref ref-type="bibr" rid="B19">1996</xref>; Chang and Balice-Gordon, <xref ref-type="bibr" rid="B8">1997</xref>; Sanes and Lichtman, <xref ref-type="bibr" rid="B23">1999</xref>; Lanuza et al., <xref ref-type="bibr" rid="B14">2001</xref>; Santaf&#x000E9; et al., <xref ref-type="bibr" rid="B26">2001</xref>; Herrera and Zeng, <xref ref-type="bibr" rid="B11">2003</xref>; Wyatt and Balice-Gordon, <xref ref-type="bibr" rid="B37">2003</xref>; Buffelli et al., <xref ref-type="bibr" rid="B5">2004</xref>; Garcia et al., <xref ref-type="bibr" rid="B10">2010</xref>). Several signaling molecules and presynaptic receptors play a role in the axonal competition, which means that the various nerve endings influence one another (Santaf&#x000E9; et al., <xref ref-type="bibr" rid="B25">2009a</xref>; Garcia et al., <xref ref-type="bibr" rid="B10">2010</xref>; Nadal et al., <xref ref-type="bibr" rid="B17">2016</xref>). Postsynaptic-derived trophic substances (Nadal et al., <xref ref-type="bibr" rid="B17">2016</xref>) and the participation of glial cells (Lee et al., <xref ref-type="bibr" rid="B15">2016</xref>; Yang et al., <xref ref-type="bibr" rid="B38">2016</xref>) also make a decisive contribution.</p>
<p>In a previous study, we investigated how individual muscarinic acetylcholine receptor (mAChR) subtypes (M<sub>1</sub>, M<sub>2</sub> and M<sub>4</sub>), adenosine receptors (AR; A<sub>1</sub> and A<sub>2A</sub>) and tropomyosin-related tyrosine kinase B (TrkB) receptors are involved in the control of synapse elimination in the mouse NMJ (Nadal et al., <xref ref-type="bibr" rid="B17">2016</xref>). The data show that mAChR, AR and TrkB signaling lessen the initial chance of axonal elimination (around P5&#x02013;P7) by extending the period of axonal competition but then increase (around P9) axonal loss rate (Nadal et al., <xref ref-type="bibr" rid="B17">2016</xref>). The three receptor sets promote axonal disconnection at the beginning of the second postnatal week largely independently of the postsynaptic nicotinic acetylcholine receptor (nAChR) cluster maturation. In addition, a real cooperation between some of the mAChR and AR subtypes is observed. More specifically, preliminary results show that both AR subtypes (A<sub>1</sub> and A<sub>2A</sub>) can add their independent effect on axonal loss to the effect of the M<sub>1</sub> muscarinic receptor, which leads to greater elimination because of the additive effect of the pathways (Nadal et al., <xref ref-type="bibr" rid="B17">2016</xref>).</p>
<p>In this study, we investigate whether the mAChR subtypes and the TrkB receptor also work together, and whether the respective pathway inhibitors have any additive or occlusive effects and, therefore, whether there is any real cooperation between them in synapse elimination at the NMJ. The main result shows that, like the mAChR and AR relations, the effect of M<sub>1</sub> and TrkB receptors can be added to increase axonal loss rate at P9 but that the effect of M<sub>2</sub> is largely independent of the TrkB receptors. Thus, cooperative and non-cooperative signaling contribute to synapse elimination, which highlights the importance of axonal competition and loss in the development of neural connectivity.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Animals</title>
<p>Transgenic B6.Cg-Tg (Thy1-YFP)16 Jrs/J mice were used (The Jackson Laboratory,Bar Harbor, ME, USA). The mice express spectral variants of GFP (yellow-YFP) at high levels in motor and sensory neurons, and axons are brightly fluorescent all the way to the terminals.</p>
<p>Experiments were performed on the <italic>Levator auris longus</italic> (LAL) muscle. Neonatal pups of either sex (9 days) were obtained and the date of birth was designated postnatal day 0 (P0). We minimized the variability in our measurements by carefully monitoring the timing of conception. Also, the weights of the individuals were within 5% of the mean for a given day after conception. The mice were cared for in accordance with the guidelines of the European Community&#x02019;s Council Directive of 24 November 1986 (86/609/EEC) for the humane treatment of laboratory animals. All experiments on animals have been reviewed and approved by the Animal Research Committee of the Universitat Rovira i Virgili (Reference number: 0233).</p>
</sec>
<sec id="s2-2">
<title>Injection Procedure</title>
<p>The newborn mice were anesthetized with 2% tribromoethanol (0.15 ml/10 g body weight, i.p.). Mice pups received daily subcutaneous injections in the back of the neck beginning on postnatal day 5 of one or two substances (combinations of two selective mAChR antagonists or of one mAChR antagonist plus the TrkB signaling agent TrkB-Fc). Under aseptic conditions, solutions were administered in 50 &#x003BC;l of sterile physiological saline by subcutaneous injection over the LAL external surface as described elsewhere (Lanuza et al., <xref ref-type="bibr" rid="B14">2001</xref>). The animals received four injections from postnatal day 5, and the LAL muscles were studied on day 9. Control injections were given in exactly the same way as experimental injections, using phosphate buffered saline (PBS) alone. No differences were found between the muscles injected or not with PBS, thus indicating that the injection procedure did not in itself induce changes in the overall morphology of the motor endplate and nerve terminals. The solutions were administered at a concentration in accordance with the previously reported biological action of the substance (Santaf&#x000E9; et al., <xref ref-type="bibr" rid="B32">2004</xref>, <xref ref-type="bibr" rid="B30">2015</xref>; Garcia et al., <xref ref-type="bibr" rid="B10">2010</xref>).</p>
</sec>
<sec id="s2-3">
<title>Tissue Preparation and Histochemistry</title>
<p>Neonatal pups were given a lethal dose of 2% tribromoethanol. Their heads were removed and fixed in 4% paraformaldehyde for 1.5 h. After washing in PBS, LAL muscles were removed and post-fixed for 45 min. After washing in PBS, Thy1-YFP LAL muscles were incubated in PBS containing a 1/800 dilution of 1 &#x003BC;g/ml tetramethylrhodamine conjugated &#x003B1;-bungarotoxin (&#x003B1;-BTX-TRITC; T1175, Molecular Probes, Eugene, OR, USA) for 1 h at room temperature. Whole muscles were mounted in Mowiol with p-phenylenediamide (Sigma).</p>
</sec>
<sec id="s2-4">
<title>Confocal Microscopy and Morphological Analysis</title>
<p>NMJs were analyzed using an inverted Nikon TE-2000 fluorescent microscope (Nikon, Tokyo, Japan) connected to a standard personal computer that was running image analysis software (ACT-1, Nikon). The number of axons per endplate was counted. Because of the difficulty of determining the exact number of axonal inputs for each nAChR cluster, when more than two axons converged at the same synaptic site we classified the NMJs into three groups only: junctions that were monoinnervated, doubly innervated, or innervated by three or more terminal axons. These data enabled us to calculate the &#x0201C;average number of axonal inputs&#x0201D; and the &#x0201C;percentage of polyneuronal innervation&#x0201D; for all fibers receiving two or more axons.</p>
</sec>
<sec id="s2-5">
<title>Statistical Analysis</title>
<p>All NMJs visible in their entirety were scored, with a minimum of 100 per muscle. At least six muscles were studied for each age and condition examined. Fisher&#x02019;s test was applied to compare percentages. The criterion for statistical significance was <italic>P</italic> &#x0003C; 0.05. The categories were scored and the counting was performed by a person with no knowledge of the age or treatment of the animals. The data are presented as mean &#x000B1; SD.</p>
</sec>
<sec id="s2-6">
<title>Drugs</title>
<sec id="s2-6-1">
<title>Selective M<sub>1</sub>, M<sub>2</sub> and M<sub>4</sub> mAChR Antagonists</title>
<p>The stock solutions were pirenzepine (PIR) dihydrochloride (1071, Tocris Bioscience) 10 mM; methoctramine (MET; M105, Sigma&#x02014;Aldrich, St. Louis, MO, USA) 1 mM; muscarinic toxin 3 (MT3; M-140, Alomone Labs) 50 &#x003BC;M. The working solutions used were PIR (10 &#x003BC;M), MET (1 &#x003BC;M) and MT3 (100 nM).</p>
</sec>
<sec id="s2-6-2">
<title>TrkB Receptor-Related Agent</title>
<p>The following stock solutions were used: recombinant human trkB/Fc Chimera (trkB-Fc; 688-TK; R&#x00026;D Systems), 100 &#x003BC;g/ml. Working solutions were trkB-Fc 5 &#x003BC;g/ml.</p>
</sec>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>mAChR and TrkB Receptors in Axon Loss Control</title>
<p>Figure <xref ref-type="fig" rid="F1">1A</xref> shows representative confocal immunofluorescence images of the autofluorescent axons in singly- and polyinnervated LAL P9 NMJs from B6.Cg-Tg (Thy1-YFP) mice (hereafter YFP). When the mAChR subtype-selective inhibitors PIR (M<sub>1</sub> blocker) and MET (M<sub>2</sub> blocker), and the TrkB pathway blocker (a TrkB-Fc chimera) were applied once a day between P5-P8 on the LAL muscle surface, there was a notable delay in the transition to monoinnervation on the NMJ observed at P9 (Nadal et al., <xref ref-type="bibr" rid="B17">2016</xref>). However, the M<sub>4</sub> subtype blocker MT3 shows no effect on axonal loss at this time. Figure <xref ref-type="fig" rid="F1">1B</xref> shows the effect of these selective blockers in increasing order of their relative ability to delay monoinnervation and maintain a high percentage of synapses innervated by three or more axons (PBS-P9 = MT3 &#x0003C; TrkB-Fc &#x0003C; PIR &#x0003C; MET). MET and PIR delayed the three-to-one axon transition whereas TrkB-Fc delayed the two-to-one transition. Therefore, in normal conditions without inhibitors, the two receptor sets (mAChR and TrkB) will contribute to promoting axonal disconnection at the beginning of the second postnatal week (see also Nadal et al., <xref ref-type="bibr" rid="B17">2016</xref>). However, the absolute potency of these receptors in modulating synapse loss cannot be directly compared because the blocking efficacy of the respective selective inhibitors is not the same.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>The picture in (A)</bold> shows representative confocal immunofluorescence images of singly-, dually- and polyinnervated neuromuscular junction area (NMJ) from P9 YFP mice. Scale bar: 10 &#x003BC;m. The histograms in <bold>(B)</bold> show the percentage of singly-, doubly- and triply- (or more) innervated NMJs in control (phosphate buffered saline, PBS treated) and levator auris longus (LAL) muscles treated with the inhibitors considered. We show newly reproduced data of previous results to facilitate comparison (Nadal et al., <xref ref-type="bibr" rid="B17">2016</xref>). <bold>(C)</bold> shows the percentage of NMJs after the simultaneous inhibition of two receptors clearly involved in axonal elimination (those that affect axon loss rate when they are individually blocked (all except M<sub>4</sub>). The associations of the M<sub>4</sub> blocker muscarinic toxin 3 (MT3) with the other inhibitors are represented in <bold>(D)</bold>. An overall representation of the data illustrating the individual role and cooperation of the muscarinic acetylcholine receptor (mAChR) and tyrosine kinase B (TrkB) receptors in developmental axonal loss modulation is shown in the diagram in <bold>(E)</bold>. The green arrows show how effective these receptors are at accelerating axonal elimination (the thicker they are, the greater their effect). The association of the M<sub>1</sub> and TrkB blockers results in the addition of their respective effects (blue bond between these receptors). The M<sub>4</sub> receptor, which does not by itself affect axonal elimination (black arrow), cooperates positively with M<sub>2</sub> (dotted green arrow) and produces some occlusion of the TrkB pathway (red arrow) but does not cooperate with M<sub>1</sub> (dotted black arrow). All NMJs visible in their entirety were scored, with a minimum of 100 synapses per muscle. At least six muscles were studied for each age and condition examined. Fisher&#x02019;s test was applied to compare percentages. When the corresponding antagonist or combinations of two substances were compared with control PBS, significance symbols are: *<italic>P</italic> &#x0003C; 0.05, ***<italic>P</italic> &#x0003C; 0.005. <sup>&#x000A7;</sup><italic>P</italic> &#x0003C; 0.05, <sup>&#x000A7;&#x000A7;</sup><italic>P</italic> &#x0003C; 0.01, <sup>&#x000A7;&#x000A7;&#x000A7;</sup><italic>P</italic> &#x0003C; 0.005 when the combination of two substances were compared with the first. <sup>&#x02021;</sup><italic>P</italic> &#x0003C; 0.05, <sup>&#x02021;&#x02021;&#x02021;</sup><italic>P</italic> &#x0003C; 0.005 when the combination of two substances were compared with the second.</p></caption>
<graphic xlink:href="fnagi-09-00024-g0001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Cooperation Between mAChR and TrkB Receptors</title>
<p>Our experiments were designed to investigate the effect on axonal loss of simultaneous incubation with two inhibitors (two antagonists of two different receptors) and reveal the possible occlusive or additive crosstalk effects between the corresponding pathways. Figures <xref ref-type="fig" rid="F1">1C,D</xref> show the effect of the association of the drugs applied between P5 and P8 and observed at P9. Figure <xref ref-type="fig" rid="F1">1C</xref> shows the percentage of NMJs&#x02014;of singly-, doubly- and triply- (or more) innervated endplates&#x02014;after the simultaneous inhibition of two receptors that, individually, clearly modulate axon loss (see Figure <xref ref-type="fig" rid="F1">1B</xref>; all except M<sub>4</sub>). The associations of the M<sub>4</sub> blocker MT3 (which does not affect axonal elimination by itself) with the other substances has been represented separately in Figure <xref ref-type="fig" rid="F1">1D</xref> so that the data is more understandable. The M<sub>4</sub> subtype is shown to have a complementary role.</p>
<p>The association of the mAChR blockers PIR and MET shows no additive effect or mutual occlusion in relation to axonal loss (Figure <xref ref-type="fig" rid="F1">1C</xref>). However, the association of the M<sub>1</sub> and TrkB pathway inhibitors (PIR plus TrkB-Fc) results in a clear addition of their respective delaying effects on axonal loss. The percentage of the monoinnervated NMJ after simultaneous exposure to both inhibitors is significantly less (25% of single junctions) than after exposure to only PIR (39%) or only TrkB-Fc (43%). Interestingly, however, the individual effect of the TrkB-Fc does not add to the effect of MET and the result of this dual drug incubation is no different from the effect of MET by itself. The delaying effect of MET on axon loss is the most potent observed in the present experiments and is produced independently of the state of TrkB.</p>
<p>Figure <xref ref-type="fig" rid="F1">1B</xref> shows that the M<sub>4</sub> blocker MT3 by itself has no effect on axonal loss at P9. Figure <xref ref-type="fig" rid="F1">1D</xref> shows that if MT3 is simultaneously applied with the other blockers it reveal some regulatory or complementary role of M<sub>4</sub> on the other receptors. The presence of MT3 does not change the effect of PIR although some occlusion of the potent effect of MET is observed. MET still continues to significantly delay axon loss (the three-to-one transition), however. Interestingly, the presence of MT3 potentiates the delaying effect of TrkB-Fc on axonal loss, which indicates that the respective receptor pathways (M<sub>4</sub> and TrkB) are cooperating.</p>
<p>These data are represented in Figure <xref ref-type="fig" rid="F1">1E</xref>. The green arrows of different thicknesses show how effective these receptors are at accelerating axonal elimination (the thicker they are, the greater their effect; the inhibitor used is in brackets under the name of the receptor). The M<sub>4</sub> receptor by itself does not affect axonal elimination at P9 (black arrow). Interestingly, the association of the M<sub>1</sub> and TrkB pathway blockers results in the addition of their respective delaying effects on axonal loss, which indicates that the corresponding receptors are cooperating (blue bond between these receptor pathways). However, the potent effect of the M<sub>2</sub> cannot be modified with the simultaneous presence of the M<sub>1</sub> or TrkB blockers. It seems that the M<sub>4</sub> receptor, which does not by itself affect axonal elimination, cooperates positively with M<sub>2</sub> (dotted green arrow). Also, M<sub>4</sub> produces some occlusion of the TrkB pathway (red arrow) but does not cooperate with M<sub>1</sub> (dotted black arrow).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>The present experiments show evidence of the cooperation between the presynaptic M<sub>1</sub>, M<sub>2</sub> and M<sub>4</sub> mAChR subtypes and the TrkB signaling to modulate the conditions of the developmental axonal competition and loss. In a previous study we found that these receptors (as well as presynaptic AR, A<sub>1</sub> and A<sub>2A</sub> subtypes) separately contribute to accelerate synapse elimination around P9 in the mouse NMJ (Nadal et al., <xref ref-type="bibr" rid="B17">2016</xref>). It was thought that the muscarinic autoreceptors of the transmitter acetylcholine (ACh) may allow direct competitive interaction between nerve endings through a differential activity-dependent ACh release. The more active axons may directly punish the less active ones or reward themselves (Santaf&#x000E9; et al., <xref ref-type="bibr" rid="B25">2009a</xref>). However, an axon that is eliminated at one NMJ may be successful at another (Tom&#x000E0;s et al., <xref ref-type="bibr" rid="B36">2011</xref>), which suggests that other receptors and local postsynaptic- (and glial cell) derived factors are involved. The involvement of the TrkB signaling described may allow a postsynaptic-derived trophic substance such as Brain-derived neurotrophic factor (BDNF) or neurotrophin-4 (NT-4) to make a contribution (Yoshii and Constantine-Paton, <xref ref-type="bibr" rid="B39">2010</xref>).</p>
<p>Interestingly, we observed that both the presynaptic-derived signal (ACh acting on axonal M<sub>1</sub> and M<sub>2</sub> mAChRs) and the TrkB-mediated signal (which may be originated by a postsynaptic-derived NT) have the same effect: namely, the acceleration of supernumerary nerve ending elimination. It seems that the outstanding regulatory resources in the NMJ synaptogenesis are committed to achieving monoinnervation. These presynaptic receptors converge in a common intracellular mechanism and a limited repertoire of effector kinases to phosphorylate protein targets and bring about structural and functional changes leading to axon loss. It is well known that in most cells M<sub>1</sub> and TrkB operate by stimulating the phospholipase C gamma (PLC gamma) and therefore the protein kinase C (PKC) pathway along with the inositol triphosphate (IP3) pathway, whereas M<sub>2</sub>&#x02013;M<sub>4</sub> inhibit the adenyl cyclase (AC) and protein kinase A (PKA) pathway (Caulfield, <xref ref-type="bibr" rid="B7">1993</xref>; Felder, <xref ref-type="bibr" rid="B9">1995</xref>; Caulfield and Birdsall, <xref ref-type="bibr" rid="B6">1998</xref>; Nathanson, <xref ref-type="bibr" rid="B18">2000</xref>). In all cases, however, common final changes such as intracellular calcium oscillations can occur (Santaf&#x000E9; et al., <xref ref-type="bibr" rid="B28">2006</xref>; Amaral and Pozzo-Miller, <xref ref-type="bibr" rid="B1">2012</xref>). Both PKA and PKC activity changes have been shown to affect pre- and postsynaptic maturation (Lanuza et al., <xref ref-type="bibr" rid="B14">2001</xref>, <xref ref-type="bibr" rid="B13">2002</xref>). Our present data can be related with the intracellular coupling of the receptors to these serine kinases. Though the blocking efficacy of the selective inhibitors of the muscarinic receptors is not assessed here, M<sub>2</sub> increases the axonal loss rate most with a slight involvement of the M<sub>4</sub> receptor but independently of the M<sub>1</sub> and TrkB receptors. This suggests that downregulation of PKA activity through the couple M<sub>2</sub>&#x02013;M<sub>4</sub> is a key factor in synapse elimination. Concurrently, M<sub>1</sub> and TrkB also contribute separately to axonal loss, but their combined action has a potent summed effect similar to the effect of the M<sub>2</sub> receptor. This suggest that activation of the PLC gamma-PKC pathway through the couple M<sub>1</sub>-TrkB may be the other key factor in this process. Thus, a displacement of the PKA/PKC activity ratio to lower values (inhibition of PKA and/or stimulation of PKC) in some nerve endings may have a leading role in synapse elimination. In this context, blockade of PKC in the newborn LAL muscle produces an initial blockade of synapse elimination and a subsequent delay (Lanuza et al., <xref ref-type="bibr" rid="B13">2002</xref>).</p>
<p>In fact, these changes in the kinase activity leading to synapse elimination must occur at least (but not only) in the weakest axons during the competitive interactions. The neurotransmitter release capacity is an important factor in the competing capacity of the various nerve terminals in a NMJ. During development, in the polyinnervated NMJ several nerve endings with different levels of maturation and ACh release capacity get together and compete. The coupling to neurotransmitter release of the considered receptors and kinases is not the same in each of these various endings themselves and in the mature synapses in the adult (Tom&#x000E0;s et al., <xref ref-type="bibr" rid="B35">2014</xref>). So, how does the specific coupling to ACh release of receptors and kinases in the weak and strong axons in competition contribute to axonal loss? As far as serine kinases are concerned, in the adult motor nerve endings both PKA and PKC potentiate ACh release when coupled to neurotransmission (Santaf&#x000E9; et al., <xref ref-type="bibr" rid="B24">2009b</xref>). Similarly, the same potentiation is observed in most neuromuscular synapses during development as, for instance, in those formed by the strongest axons (those that evoke the large endplate potential, EPP) in the polyinnervated junctions (Santaf&#x000E9; et al., <xref ref-type="bibr" rid="B32">2004</xref>). However, in the weakest endings the inhibition of PKC increases the evoked EPP size indicating that, in normal conditions without any inhibition, this kinase tonically couples to ACh release reduction in these low releasing synapses. Therefore, an M<sub>1</sub>-TrkB-mediated increase in PKC activity in the weakest endings would debilitate further their ACh release capacity and competitive force and facilitate their elimination. In addition, an M<sub>2</sub>-mediated PKA downregulation in all nerve endings in competition may differentially affect their ACh release and contribute to elimination. Thus, at this point, there is a significant agreement between the known involvement of these molecules in neurotransmission and axon loss.</p>
<p>However, when considering the real postnatal coupling to ACh release of the mAChR and the TrkB receptor in the different nerve endings (the strongest and the weakest) on developing synapses (Santaf&#x000E9; et al., <xref ref-type="bibr" rid="B32">2004</xref>; Garcia et al., <xref ref-type="bibr" rid="B10">2010</xref>), additional interpretative keys are needed. In the mature NMJ, M<sub>1</sub> and M<sub>2</sub> subtypes modulate evoked transmitter release by positive and negative feedbacks, respectively (Santaf&#x000E9; et al., <xref ref-type="bibr" rid="B31">2003</xref>, <xref ref-type="bibr" rid="B28">2006</xref>). However, during NMJ synaptogenesis, the functional significance of the subtypes is different from in the adult. M<sub>2</sub> receptors promote release in all nerve endings independently of their ACh release level or maturation state whereas an M<sub>1</sub>- and M<sub>4</sub>-mediated reduction in release is observed in the weakest endings on dual junctions (Santaf&#x000E9; et al., <xref ref-type="bibr" rid="B26">2001</xref>, <xref ref-type="bibr" rid="B27">2002</xref>, <xref ref-type="bibr" rid="B31">2003</xref>, <xref ref-type="bibr" rid="B32">2004</xref>, <xref ref-type="bibr" rid="B29">2007</xref>, <xref ref-type="bibr" rid="B25">2009a</xref>). Similarly, the BDNF-TrkB pathway contributes to potentiate ACh release in different neuromuscular adult models but the potentiation is not observed in the weakest nerve endings during development and even some ACh release inhibition was observed in the strongest endings (Garcia et al., <xref ref-type="bibr" rid="B10">2010</xref>). Therefore, interpreting the links and molecular relations between transmitter release and elimination of nerve terminals seems more complex than it seemed at first. The involvement of other signaling such as AR can contribute to this complexity (Todd and Robitaille, <xref ref-type="bibr" rid="B34">2006</xref>; Nadal et al., <xref ref-type="bibr" rid="B17">2016</xref>). However, some conclusions can be drawn on the basis of all the above data. First, it should be pointed out that, contrary to what happens in the adult, M<sub>1</sub> (and M<sub>4</sub>) and PKC activity reduces ACh release in the weakest endings and promotes axonal loss. In fact, blocking mAChRs (M<sub>1</sub>- and/or M<sub>4</sub>-subtypes) or PKC or voltage-dependent calcium channels (VDCCs; P/Q-, N- or L-type or Ca<sup>2+</sup> influx) can lead to similar percentage increases in the size of the synaptic potentials evoked by weak axons (Santaf&#x000E9; et al., <xref ref-type="bibr" rid="B31">2003</xref>, <xref ref-type="bibr" rid="B32">2004</xref>, <xref ref-type="bibr" rid="B29">2007</xref>, <xref ref-type="bibr" rid="B25">2009a</xref>,<xref ref-type="bibr" rid="B24">b</xref>; Tom&#x000E0;s et al., <xref ref-type="bibr" rid="B36">2011</xref>). Therefore, the M<sub>1</sub>-PKC pathway may debilitate the ACh release capacity and competitive force of these synaptic contacts and facilitate their elimination. The final target molecules involved may be the VDCC, specially the L-type which is exclusively coupled to ACh release in these weak endings (Santaf&#x000E9; et al., <xref ref-type="bibr" rid="B26">2001</xref>) and may contribute to carry high calcium near the molecular mechanism directly involved in axon loss. Second, like M<sub>1</sub> signaling, BDNF-TrkB signaling accelerates axon loss. However, it is not so clear whether it is involved in the modulation of ACh release in the nerve endings that are in competition because it does not affect release in the weak axons. Because PKC effectively reduces release in these endings, the TrkB pathway may operate through the IP3 pathway to increase intracellular calcium and modulate the loss of axons. Third, M<sub>2</sub> promotes axonal elimination the most. However, unlike the adult, this muscarinic subtype promotes ACh release in all the endings that are in competition, including the weakest endings and the solitary ending that finally wins the competition. Therefore, there is a shift in the M<sub>2</sub> coupling during development but how this affects its relation with PKA and how this relates with axonal loss is not known.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>LN: data collection, quantitative analysis, literature search and data interpretation; EH, AS and MT: data collection, NG: statistics; JT, NG and MAL: conception and design, literature search, data interpretation, confocal microscopy and manuscript preparation. JT, NG and MAL contributed equally to this work. All authors listed, have made substantial, direct and intellectual contribution to the work, and approved it for publication.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work was supported by a grant from the Catalan Government (2014SGR344) and a grant from Ministerio de Econom&#x000ED;a y Competitividad (MINECO; SAF2015-67143-P).</p>
</sec>
<sec id="s8">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amaral</surname> <given-names>M. D.</given-names></name> <name><surname>Pozzo-Miller</surname> <given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Intracellular Ca2<sup>+</sup> stores and Ca2<sup>+</sup> influx are both required for BDNF to rapidly increase quantal vesicular transmitter release</article-title>. <source>Neural Plast.</source> <volume>2012</volume>, <fpage>2012</fpage>&#x02013;<lpage>203536</lpage>. <pub-id pub-id-type="doi">10.1155/2012/203536</pub-id><pub-id pub-id-type="pmid">22811938</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benoit</surname> <given-names>P.</given-names></name> <name><surname>Changeux</surname> <given-names>J. P.</given-names></name></person-group> (<year>1975</year>). <article-title>Consequences of tenotomy on the evolution of multiinnervation in developing rat soleus muscle</article-title>. <source>Brain Res.</source> <volume>99</volume>, <fpage>354</fpage>&#x02013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(75)90036-0</pub-id><pub-id pub-id-type="pmid">1182551</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bourgeois</surname> <given-names>J. P.</given-names></name> <name><surname>Rakic</surname> <given-names>P.</given-names></name></person-group> (<year>1993</year>). <article-title>Changes of synaptic density in the primary visual cortex of the macaque monkey from fetal to adult stage</article-title>. <source>J. Neurosci.</source> <volume>13</volume>, <fpage>2801</fpage>&#x02013;<lpage>2820</lpage>. <pub-id pub-id-type="pmid">8331373</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>M. C.</given-names></name> <name><surname>Jansen</surname> <given-names>J. K.</given-names></name> <name><surname>Van Essen</surname> <given-names>D.</given-names></name></person-group> (<year>1976</year>). <article-title>Polyneuronal innervation of skeletal muscle in new-born rats and its elimination during maturation</article-title>. <source>J. Physiol.</source> <volume>261</volume>, <fpage>387</fpage>&#x02013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1976.sp011565</pub-id><pub-id pub-id-type="pmid">978579</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buffelli</surname> <given-names>M.</given-names></name> <name><surname>Busetto</surname> <given-names>G.</given-names></name> <name><surname>Bidoia</surname> <given-names>C.</given-names></name> <name><surname>Favero</surname> <given-names>M.</given-names></name> <name><surname>Cangiano</surname> <given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>Activity-dependent synaptic competition at mammalian neuromuscular junctions</article-title>. <source>News Physiol. Sci.</source> <volume>19</volume>, <fpage>85</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1152/nips.01464.2003</pub-id><pub-id pub-id-type="pmid">15143199</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caulfield</surname> <given-names>M. P.</given-names></name></person-group> (<year>1993</year>). <article-title>Muscarinic receptors&#x02013;characterization, coupling and function</article-title>. <source>Pharmacol. Ther.</source> <volume>58</volume>, <fpage>319</fpage>&#x02013;<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1016/0163-7258(93)90027-b</pub-id><pub-id pub-id-type="pmid">7504306</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caulfield</surname> <given-names>M. P.</given-names></name> <name><surname>Birdsall</surname> <given-names>N. J.</given-names></name></person-group> (<year>1998</year>). <article-title>International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors</article-title>. <source>Pharmacol. Rev.</source> <volume>50</volume>, <fpage>279</fpage>&#x02013;<lpage>290</lpage>. <pub-id pub-id-type="pmid">9647869</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>Q.</given-names></name> <name><surname>Balice-Gordon</surname> <given-names>R. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Nip and tuck at the neuromuscular junction: a role for proteases in developmental synapse elimination</article-title>. <source>Bioessays</source> <volume>19</volume>, <fpage>271</fpage>&#x02013;<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1002/bies.950190402</pub-id><pub-id pub-id-type="pmid">9136623</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Felder</surname> <given-names>C. C.</given-names></name></person-group> (<year>1995</year>). <article-title>Muscarinic acetylcholine receptors: signal transduction through multiple effectors</article-title>. <source>FASEB J.</source> <volume>9</volume>, <fpage>619</fpage>&#x02013;<lpage>625</lpage>. <pub-id pub-id-type="pmid">7768353</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>M.</given-names></name> <name><surname>Santaf&#x000E9;</surname> <given-names>M. M.</given-names></name> <name><surname>Besalduch</surname> <given-names>N.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>The interaction between tropomyosin-related kinase B receptors and presynaptic muscarinic receptors modulates transmitter release in adult rodent motor nerve terminals</article-title>. <source>J. Neurosci.</source> <volume>30</volume>, <fpage>16514</fpage>&#x02013;<lpage>16522</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2676-10.2010</pub-id><pub-id pub-id-type="pmid">21147991</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herrera</surname> <given-names>A. A.</given-names></name> <name><surname>Zeng</surname> <given-names>Y.</given-names></name></person-group> (<year>2003</year>). <article-title>Activity-dependent switch from synapse formation to synapse elimination during development of neuromuscular junctions</article-title>. <source>J. Neurocytol.</source> <volume>32</volume>, <fpage>817</fpage>&#x02013;<lpage>833</lpage>. <pub-id pub-id-type="doi">10.1023/b:neur.0000020626.29900.fb</pub-id><pub-id pub-id-type="pmid">15034270</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname> <given-names>J. K.</given-names></name> <name><surname>Fladby</surname> <given-names>T.</given-names></name></person-group> (<year>1990</year>). <article-title>The perinatal reorganization of the innervation of skeletal muscle in mammals</article-title>. <source>Prog. Neurobiol.</source> <volume>34</volume>, <fpage>39</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/0301-0082(90)90025-c</pub-id><pub-id pub-id-type="pmid">2406795</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Santaf&#x000E9;</surname> <given-names>M.</given-names></name> <name><surname>Gonz&#x000E1;lez</surname> <given-names>C. M.</given-names></name> <name><surname>Alonso</surname> <given-names>I.</given-names></name> <name><surname>Nelson</surname> <given-names>P. G.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Pre- and postsynaptic maturation of the neuromuscular junction during neonatal synapse elimination depends on protein kinase C</article-title>. <source>J. Neurosci. Res.</source> <volume>67</volume>, <fpage>607</fpage>&#x02013;<lpage>617</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.10122</pub-id><pub-id pub-id-type="pmid">11891773</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Santaf&#x000E9;</surname> <given-names>M.</given-names></name> <name><surname>Nelson</surname> <given-names>P. G.</given-names></name> <name><surname>Fenoll-Brunet</surname> <given-names>M. R.</given-names></name> <name><surname>Tomas</surname> <given-names>J.</given-names></name></person-group> (<year>2001</year>). <article-title>Pertussis toxin-sensitive G-protein and protein kinase C activity are involved in normal synapse elimination in the neonatal rat muscle</article-title>. <source>J. Neurosci. Res.</source> <volume>63</volume>, <fpage>330</fpage>&#x02013;<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1002/1097-4547(20010215)63:4&#x0003C;330::aid-jnr1027&#x0003E;3.0.co;2-w</pub-id><pub-id pub-id-type="pmid">11170183</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Mikesh</surname> <given-names>M.</given-names></name> <name><surname>Smith</surname> <given-names>I.</given-names></name> <name><surname>Nave</surname> <given-names>K.-A.</given-names></name> <name><surname>Schwab</surname> <given-names>M. H.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Neuregulin1 displayed on motor axons regulates terminal Schwann cell-mediated synapse elimination at developing neuromuscular junctions</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>113</volume>, <fpage>E479</fpage>&#x02013;<lpage>E487</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1519156113</pub-id><pub-id pub-id-type="pmid">26755586</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Fields</surname> <given-names>R. D.</given-names></name> <name><surname>Festoff</surname> <given-names>B. W.</given-names></name> <name><surname>Nelson</surname> <given-names>P. G.</given-names></name></person-group> (<year>1994</year>). <article-title>Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>91</volume>, <fpage>10300</fpage>&#x02013;<lpage>10304</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.91.22.10300</pub-id><pub-id pub-id-type="pmid">7524091</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nadal</surname> <given-names>L.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Hurtado</surname> <given-names>E.</given-names></name> <name><surname>Sim&#x000F3;</surname> <given-names>A.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>M.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Presynaptic muscarinic acetylcholine autoreceptors (M1, M2 and M4 subtypes), adenosine receptors (A1 and A2A) and tropomyosin-related kinase B receptor (TrkB) modulate the developmental synapse elimination process at the neuromuscular junction</article-title>. <source>Mol. Brain</source> <volume>9</volume>:<fpage>67</fpage>. <pub-id pub-id-type="doi">10.1186/s13041-016-0248-9</pub-id><pub-id pub-id-type="pmid">27339059</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nathanson</surname> <given-names>N. M.</given-names></name></person-group> (<year>2000</year>). <article-title>A multiplicity of muscarinic mechanisms: enough signaling pathways to take your breath away</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>97</volume>, <fpage>6245</fpage>&#x02013;<lpage>6247</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.97.12.6245</pub-id><pub-id pub-id-type="pmid">10841527</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>Q. T.</given-names></name> <name><surname>Lichtman</surname> <given-names>J. W.</given-names></name></person-group> (<year>1996</year>). <article-title>Mechanism of synapse disassembly at the developing neuromuscular junction</article-title>. <source>Curr. Opin. Neurobiol.</source> <volume>6</volume>, <fpage>104</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/s0959-4388(96)80015-8</pub-id><pub-id pub-id-type="pmid">8794054</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname> <given-names>R. A.</given-names></name> <name><surname>Ostberg</surname> <given-names>A. J.</given-names></name> <name><surname>Vrbov&#x000E1;</surname> <given-names>G.</given-names></name></person-group> (<year>1978</year>). <article-title>Observations on the elimination of polyneuronal innervation in developing mammalian skeletal muscle</article-title>. <source>J. Physiol.</source> <volume>282</volume>, <fpage>571</fpage>&#x02013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1978.sp012482</pub-id><pub-id pub-id-type="pmid">722562</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redfern</surname> <given-names>P. A.</given-names></name></person-group> (<year>1970</year>). <article-title>Neuromuscular transmission in new-born rats</article-title>. <source>J. Physiol.</source> <volume>209</volume>, <fpage>701</fpage>&#x02013;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1970.sp009187</pub-id><pub-id pub-id-type="pmid">5499804</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribchester</surname> <given-names>R. R.</given-names></name> <name><surname>Barry</surname> <given-names>J. A.</given-names></name></person-group> (<year>1994</year>). <article-title>Spatial versus consumptive competition at polyneuronally innervated neuromuscular junctions</article-title>. <source>Exp. Physiol.</source> <volume>79</volume>, <fpage>465</fpage>&#x02013;<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1113/expphysiol.1994.sp003781</pub-id><pub-id pub-id-type="pmid">7946277</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanes</surname> <given-names>J. R.</given-names></name> <name><surname>Lichtman</surname> <given-names>J. W.</given-names></name></person-group> (<year>1999</year>). <article-title>Development of the vertebrate neuromuscular junction</article-title>. <source>Annu. Rev. Neurosci.</source> <volume>22</volume>, <fpage>389</fpage>&#x02013;<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.22.1.389</pub-id><pub-id pub-id-type="pmid">10202544</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santaf&#x000E9;</surname> <given-names>M. M.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>M.</given-names></name> <name><surname>Besalduch</surname> <given-names>N.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>J.</given-names></name></person-group> (<year>2009a</year>). <article-title>Presynaptic muscarinic receptors, calcium channels, and protein kinase C modulate the functional disconnection of weak inputs at polyinnervated neonatal neuromuscular synapses</article-title>. <source>J. Neurosci. Res.</source> <volume>87</volume>, <fpage>1195</fpage>&#x02013;<lpage>1206</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.21934</pub-id><pub-id pub-id-type="pmid">19006081</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santaf&#x000E9;</surname> <given-names>M. M.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>M.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>J.</given-names></name></person-group> (<year>2009b</year>). <article-title>Interaction between protein kinase C and protein kinase A can modulate transmitter release at the rat neuromuscular synapse</article-title>. <source>J. Neurosci. Res.</source> <volume>87</volume>, <fpage>683</fpage>&#x02013;<lpage>690</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.21885</pub-id><pub-id pub-id-type="pmid">18816790</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santaf&#x000E9;</surname> <given-names>M. M.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Uchitel</surname> <given-names>O. D.</given-names></name> <name><surname>Salon</surname> <given-names>I.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Decreased calcium influx into the neonatal rat motor nerve terminals can recruit additional neuromuscular junctions during the synapse elimination period</article-title>. <source>Neuroscience</source> <volume>110</volume>, <fpage>147</fpage>&#x02013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-4522(01)00543-7</pub-id><pub-id pub-id-type="pmid">11882379</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santaf&#x000E9;</surname> <given-names>M. M.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Uchitel</surname> <given-names>O. D.</given-names></name> <name><surname>Tom&#x000E1;s</surname> <given-names>J.</given-names></name></person-group> (<year>2001</year>). <article-title>Calcium channels coupled to neurotransmitter release at dually innervated neuromuscular junctions in the newborn rat</article-title>. <source>Neuroscience</source> <volume>102</volume>, <fpage>697</fpage>&#x02013;<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1016/s0306-4522(00)00507-8</pub-id><pub-id pub-id-type="pmid">11226706</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santaf&#x000E9;</surname> <given-names>M. M.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Muscarinic autoreceptors modulate transmitter release through protein kinase C and protein kinase A in the rat motor nerve terminal</article-title>. <source>Eur. J. Neurosci.</source> <volume>23</volume>, <fpage>2048</fpage>&#x02013;<lpage>2056</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04753.x</pub-id><pub-id pub-id-type="pmid">16630052</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santaf&#x000E9;</surname> <given-names>M. M.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>M.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Coupling of presynaptic muscarinic autoreceptors to serine kinases in low and high release conditions on the rat motor nerve terminal</article-title>. <source>Neuroscience</source> <volume>148</volume>, <fpage>432</fpage>&#x02013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.06.017</pub-id><pub-id pub-id-type="pmid">17681697</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santaf&#x000E9;</surname> <given-names>M. M.</given-names></name> <name><surname>Priego</surname> <given-names>M.</given-names></name> <name><surname>Obis</surname> <given-names>T.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>M.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Adenosine receptors and muscarinic receptors cooperate in acetylcholine release modulation in the neuromuscular synapse</article-title>. <source>Eur. J. Neurosci.</source> <volume>42</volume>, <fpage>1775</fpage>&#x02013;<lpage>1787</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.12922</pub-id><pub-id pub-id-type="pmid">25892551</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santaf&#x000E9;</surname> <given-names>M. M.</given-names></name> <name><surname>Salon</surname> <given-names>I.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Uchitel</surname> <given-names>O. D.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>J.</given-names></name></person-group> (<year>2003</year>). <article-title>Modulation of ACh release by presynaptic muscarinic autoreceptors in the neuromuscular junction of the newborn and adult rat</article-title>. <source>Eur. J. Neurosci.</source> <volume>17</volume>, <fpage>119</fpage>&#x02013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.2003.02428.x</pub-id><pub-id pub-id-type="pmid">12534975</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santaf&#x000E9;</surname> <given-names>M. M.</given-names></name> <name><surname>Salon</surname> <given-names>I.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Uchitel</surname> <given-names>O. D.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Muscarinic autoreceptors related with calcium channels in the strong and weak inputs at polyinnervated developing rat neuromuscular junctions</article-title>. <source>Neuroscience</source> <volume>123</volume>, <fpage>61</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2003.09.012</pub-id><pub-id pub-id-type="pmid">14667442</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname> <given-names>W. J.</given-names></name></person-group> (<year>1985</year>). <article-title>Activity and synapse elimination at the neuromuscular junction</article-title>. <source>Cell. Mol. Neurobiol.</source> <volume>5</volume>, <fpage>167</fpage>&#x02013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1007/bf00711091 </pub-id><pub-id pub-id-type="pmid">3861262</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname> <given-names>K. J.</given-names></name> <name><surname>Robitaille</surname> <given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Purinergic modulation of synaptic signalling at the neuromuscular junction</article-title>. <source>Pflugers Arch.</source> <volume>452</volume>, <fpage>608</fpage>&#x02013;<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-006-0068-3</pub-id><pub-id pub-id-type="pmid">16604367</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tom&#x000E0;s</surname> <given-names>J.</given-names></name> <name><surname>Santaf&#x000E9;</surname> <given-names>M. M.</given-names></name> <name><surname>Garcia</surname> <given-names>N.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>M.</given-names></name> <name><surname>Besalduch</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Presynaptic membrane receptors in acetylcholine release modulation in the neuromuscular synapse</article-title>. <source>J. Neurosci. Res.</source> <volume>92</volume>, <fpage>543</fpage>&#x02013;<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23346</pub-id><pub-id pub-id-type="pmid">24464361</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tom&#x000E0;s</surname> <given-names>J.</given-names></name> <name><surname>Santaf&#x000E9;</surname> <given-names>M. M.</given-names></name> <name><surname>Lanuza</surname> <given-names>M. A.</given-names></name> <name><surname>Garc&#x000ED;a</surname> <given-names>N.</given-names></name> <name><surname>Besalduch</surname> <given-names>N.</given-names></name> <name><surname>Tom&#x000E0;s</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Silent synapses in neuromuscular junction development</article-title>. <source>J. Neurosci. Res.</source> <volume>89</volume>, <fpage>3</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.22494</pub-id><pub-id pub-id-type="pmid">20857511</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wyatt</surname> <given-names>R. M.</given-names></name> <name><surname>Balice-Gordon</surname> <given-names>R. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Activity-dependent elimination of neuromuscular synapses</article-title>. <source>J. Neurocytol.</source> <volume>32</volume>, <fpage>777</fpage>&#x02013;<lpage>794</lpage>. <pub-id pub-id-type="doi">10.1023/b:neur.0000020623.62043.33</pub-id><pub-id pub-id-type="pmid">15034267</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>J.</given-names></name> <name><surname>Yang</surname> <given-names>H.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name> <name><surname>Qin</surname> <given-names>L.</given-names></name> <name><surname>Lou</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Astrocytes contribute to synapse elimination via type 2 inositol 1,4,5-trisphosphate receptor-dependent release of ATP</article-title>. <source>ELife</source> <volume>5</volume>:<fpage>e15043</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.15043</pub-id><pub-id pub-id-type="pmid">27067238</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshii</surname> <given-names>A.</given-names></name> <name><surname>Constantine-Paton</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity and disease</article-title>. <source>Dev. Neurobiol.</source> <volume>70</volume>, <fpage>304</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.20765</pub-id><pub-id pub-id-type="pmid">20186705</pub-id></citation></ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item><term>AC</term><def><p>adenyl cyclase</p></def></def-item>
<def-item><term>ACh</term><def><p>acetylcholine</p></def></def-item>
<def-item><term>AR</term><def><p>adenosine receptors</p></def></def-item>
<def-item><term>BDNF</term><def><p>Brain-derived neurotrophic factor</p></def></def-item>
<def-item><term>EPP</term><def><p>evoke endplate potentials</p></def></def-item>
<def-item><term>IP3</term><def><p>inositol triphosphate</p></def></def-item>
<def-item><term>LAL</term><def><p>Levator auris longus muscle</p></def></def-item>
<def-item><term>mAChR</term><def><p>muscarinic acetylcholine receptor</p></def></def-item>
<def-item><term>M<sub>1</sub></term><def><p>M<sub>1</sub>-type muscarinic acetylcholine receptor</p></def></def-item>
<def-item><term>M<sub>2</sub></term><def><p>M<sub>2</sub>-type muscarinic acetylcholine receptor</p></def></def-item>
<def-item><term>M<sub>4</sub></term><def><p>M<sub>4</sub>-type muscarinic acetylcholine receptor</p></def></def-item>
<def-item><term>MET</term><def><p>methoctramine</p></def></def-item>
<def-item><term>MT-3</term><def><p>muscarinic toxin 3</p></def></def-item>
<def-item><term>nAChR</term><def><p>nicotinic acetylcholine receptor</p></def></def-item>
<def-item><term>NMJ</term><def><p>neuromuscular junction</p></def></def-item>
<def-item><term>NT-4</term><def><p>neurotrophin-4</p></def></def-item>
<def-item><term>PBS</term><def><p>phosphate buffered saline</p></def></def-item>
<def-item><term>PIR</term><def><p>pirenzepine</p></def></def-item>
<def-item><term>PKA</term><def><p>protein kinase A</p></def></def-item>
<def-item><term>PKC</term><def><p>protein kinase C</p></def></def-item>
<def-item><term>PLC</term><def><p>phospholipase C</p></def></def-item>
<def-item><term>TrkB</term><def><p>tropomyosin-related kinase B receptor</p></def></def-item>
<def-item><term>VDCC</term><def><p>voltage-dependent calcium channels.</p></def></def-item>
</def-list>
</glossary>
</back>
</article>